REPORT ID 137336

Global Sicca Syndrome Drug Market Study 2016-2026, by Segment (BMS-986142, Belimumab,

Publish Date
Nov-19
Pages
51
Format
Electronic (PDF)

ummary

The global Sicca Syndrome Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. 
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        BMS-986142
        Belimumab
        Coversin
        Filgotinib
        LY-3090106
        Others
Demand Coverage (Market Size & Forecast,  Consumer Distribution):
        Hospital
        Clinic
        Others
Company Coverage (Sales data, Main Products & Services etc.):
        Akari Therapeutics, Plc
        Amgen Inc.
        Ampio Pharmaceuticals, Inc.
        Biogen, Inc.
        Bristol-Myers Squibb Company
        GlaxoSmithKline Plc
        MedImmune, LLC
        Novartis AG
        Redx Pharma Plc
        Toleranzia AB
        UCB S.A.
Major Region Market
        North America
        Europe
        Asia-Pacific
        South America
        Middle East & Africa 
			   
Table of Content
1 Industry Overview
    1.1 Sicca Syndrome Drug Industry
        1.1.1 Overview
        1.1.2 Products of Major Companies
    1.2 Market Segment
        1.2.1 Industry Chain
        1.2.2 Consumer Distribution
    1.3 Price & Cost Overview
2 Sicca Syndrome Drug Market by Type
    2.1 By Type
       2.1.1 BMS-986142
       2.1.2 Belimumab
       2.1.3 Coversin
       2.1.4 Filgotinib
       2.1.5 LY-3090106
       2.1.6 Others
    2.2 Market Size by Type
    2.3 Market Forecast by Type
3 Global Market Demand
    3.1 Segment Overview
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Others
    3.2 Market Size by Demand
    3.3 Market Forecast by Demand
4 Major Region Market
    4.1 Global Market Overview
        4.1.1 Market Size & Growth
        4.1.2 Market Forecast
    4.2 Major Region
        4.2.1 Market Size & Growth
        4.2.2 Market Forecast
5 Major Companies List
    5.1 Akari Therapeutics, Plc (Company Profile, Sales Data etc.)
    5.2 Amgen Inc. (Company Profile, Sales Data etc.)
    5.3 Ampio Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
    5.4 Biogen, Inc. (Company Profile, Sales Data etc.)
    5.5 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
    5.6 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
    5.7 MedImmune, LLC (Company Profile, Sales Data etc.)
    5.8 Novartis AG (Company Profile, Sales Data etc.)
    5.9 Redx Pharma Plc (Company Profile, Sales Data etc.)
    5.10 Toleranzia AB (Company Profile, Sales Data etc.)
    5.11 UCB S.A. (Company Profile, Sales Data etc.)
6 Conclusion